Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Next-Gen Sequencing Has Significant Utility for Drug-Resistant Epilepsy
From - Diagnostic Testing & Emerging Technologies
Next-generation sequencing improves definitive diagnoses for children with drug-resistant epilepsy, according to a pilot study published online…
General Population Has Interest in Genetic Testing for Skin Cancer Risk
...
Already a member? Log in here
Procalcitonin Results Fail to Guide Lower Antibiotic Use
...
Already a member? Log in here
FDA Recommends Pooled of Blood Testing for Zika Virus
...
Already a member? Log in here
Urinary cfDNA Analysis Valuable for Urinary Tract Infections
From - Diagnostic Testing & Emerging Technologies
Sequencing of urinary cell-free DNA (cfDNA) offers a comprehensive examination of bacterial and viral infections of the urinary tract and could be…
PAMA Unlocks Golden Age for Innovative Diagnostics
By Chance Scott bio
The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition…
HIV Testing Opportunities Missed For High-Risk Patients
From - Diagnostic Testing & Emerging Technologies
There are many missed opportunities for testing and diagnosis of HIV among high-risk individuals seen in clinical settings…
Early Lactate Tests Impactful, But Often Not Performed With Sepsis
From - Diagnostic Testing & Emerging Technologies
Early lactate measurements appear to improve results for patients with sepsis, but initial and repeat serum lactate levels are frequently not drawn in the recommended…
Lack of Utility Evidence Still Hampers Adoption of Pharmacogenomic Testing: Benefits Seen in the Field of Psychiatry
From - Diagnostic Testing & Emerging Technologies
For years it had been hoped that pharmacogenetic (PGx) testing would be a leading application for personalized medicine…
Whole-Genome Sequencing Can Improve Blood Transfusion Matches
From - Diagnostic Testing & Emerging Technologies
Antigen typing based on whole-genome sequencing (WGS) can enable more precise matching of blood transfusions, according to a study published online May 17 in…